Global Regenerative Therapies for Osteoarthritis Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 106
Inquire Before Buying

Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.

The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.

Market Analysis and Insights: Global Regenerative Therapies for Osteoarthritis Market

The global Regenerative Therapies for Osteoarthritis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Therapies for Osteoarthritis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Therapies for Osteoarthritis market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Therapies for Osteoarthritis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Therapies for Osteoarthritis market.

Global Regenerative Therapies for Osteoarthritis Scope and Market Size

Regenerative Therapies for Osteoarthritis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Therapies for Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Cell Therapy

- Tissue Engineering

- Gene Therapy

Segment by Application

- Hospitals

- Ambulatory Surgical Centers

- Orthopaedic Clinics

- Research Institutes

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Acelity

- Mesoblast

- Nuo Therapeutics

- Astellas Pharma

- Organovo

- Orgenesis

- Sanofi

- Athersys

- Takeda

- Cytori Therapeutics

Global Regenerative Therapies for Osteoarthritis Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Gene Therapy
1.3 Market by Application
1.3.1 Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Orthopaedic Clinics
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Therapies for Osteoarthritis Market Perspective (2016-2027)
2.2 Regenerative Therapies for Osteoarthritis Growth Trends by Regions
2.2.1 Regenerative Therapies for Osteoarthritis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Regenerative Therapies for Osteoarthritis Historic Market Share by Regions (2016-2021)
2.2.3 Regenerative Therapies for Osteoarthritis Forecasted Market Size by Regions (2022-2027)
2.3 Regenerative Therapies for Osteoarthritis Industry Dynamic
2.3.1 Regenerative Therapies for Osteoarthritis Market Trends
2.3.2 Regenerative Therapies for Osteoarthritis Market Drivers
2.3.3 Regenerative Therapies for Osteoarthritis Market Challenges
2.3.4 Regenerative Therapies for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Therapies for Osteoarthritis Players by Revenue
3.1.1 Global Top Regenerative Therapies for Osteoarthritis Players by Revenue (2016-2021)
3.1.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Players (2016-2021)
3.2 Global Regenerative Therapies for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Therapies for Osteoarthritis Revenue
3.4 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio
3.4.1 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Therapies for Osteoarthritis Revenue in 2020
3.5 Regenerative Therapies for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Regenerative Therapies for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Therapies for Osteoarthritis Breakdown Data by Type
4.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Type (2016-2021)
4.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2022-2027)
5 Regenerative Therapies for Osteoarthritis Breakdown Data by Application
5.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Application (2016-2021)
5.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Regenerative Therapies for Osteoarthritis Market Size (2016-2027)
6.2 North America Regenerative Therapies for Osteoarthritis Market Size by Type
6.2.1 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021)
6.2.2 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027)
6.2.3 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2027)
6.3 North America Regenerative Therapies for Osteoarthritis Market Size by Application
6.3.1 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021)
6.3.2 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027)
6.3.3 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2027)
6.4 North America Regenerative Therapies for Osteoarthritis Market Size by Country
6.4.1 North America Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021)
6.4.2 North America Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Regenerative Therapies for Osteoarthritis Market Size (2016-2027)
7.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Type
7.2.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021)
7.2.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027)
7.2.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2027)
7.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Application
7.3.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021)
7.3.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027)
7.3.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2027)
7.4 Europe Regenerative Therapies for Osteoarthritis Market Size by Country
7.4.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021)
7.4.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size (2016-2027)
8.2 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Type
8.2.1 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2027)
8.3 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Application
8.3.1 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2027)
8.4 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Region
8.4.1 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Therapies for Osteoarthritis Market Size (2016-2027)
9.2 Latin America Regenerative Therapies for Osteoarthritis Market Size by Type
9.2.1 Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021)
9.2.2 Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027)
9.2.3 Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2027)
9.3 Latin America Regenerative Therapies for Osteoarthritis Market Size by Application
9.3.1 Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021)
9.3.2 Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027)
9.3.3 Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2027)
9.4 Latin America Regenerative Therapies for Osteoarthritis Market Size by Country
9.4.1 Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021)
9.4.2 Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size (2016-2027)
10.2 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Type
10.2.1 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2027)
10.3 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Application
10.3.1 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2027)
10.4 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Country
10.4.1 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Acelity
11.1.1 Acelity Company Details
11.1.2 Acelity Business Overview
11.1.3 Acelity Regenerative Therapies for Osteoarthritis Introduction
11.1.4 Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.1.5 Acelity Recent Development
11.2 Mesoblast
11.2.1 Mesoblast Company Details
11.2.2 Mesoblast Business Overview
11.2.3 Mesoblast Regenerative Therapies for Osteoarthritis Introduction
11.2.4 Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.2.5 Mesoblast Recent Development
11.3 Nuo Therapeutics
11.3.1 Nuo Therapeutics Company Details
11.3.2 Nuo Therapeutics Business Overview
11.3.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Introduction
11.3.4 Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.3.5 Nuo Therapeutics Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Introduction
11.4.4 Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 Organovo
11.5.1 Organovo Company Details
11.5.2 Organovo Business Overview
11.5.3 Organovo Regenerative Therapies for Osteoarthritis Introduction
11.5.4 Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.5.5 Organovo Recent Development
11.6 Orgenesis
11.6.1 Orgenesis Company Details
11.6.2 Orgenesis Business Overview
11.6.3 Orgenesis Regenerative Therapies for Osteoarthritis Introduction
11.6.4 Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.6.5 Orgenesis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Regenerative Therapies for Osteoarthritis Introduction
11.7.4 Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Athersys
11.8.1 Athersys Company Details
11.8.2 Athersys Business Overview
11.8.3 Athersys Regenerative Therapies for Osteoarthritis Introduction
11.8.4 Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.8.5 Athersys Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Regenerative Therapies for Osteoarthritis Introduction
11.9.4 Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Cytori Therapeutics
11.10.1 Cytori Therapeutics Company Details
11.10.2 Cytori Therapeutics Business Overview
11.10.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Introduction
11.10.4 Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021)
11.10.5 Cytori Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Gene Therapy
Table 5. Global Regenerative Therapies for Osteoarthritis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Regenerative Therapies for Osteoarthritis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Regenerative Therapies for Osteoarthritis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2016-2021)
Table 9. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2022-2027)
Table 11. Regenerative Therapies for Osteoarthritis Market Trends
Table 12. Regenerative Therapies for Osteoarthritis Market Drivers
Table 13. Regenerative Therapies for Osteoarthritis Market Challenges
Table 14. Regenerative Therapies for Osteoarthritis Market Restraints
Table 15. Global Regenerative Therapies for Osteoarthritis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Regenerative Therapies for Osteoarthritis Market Share by Players (2016-2021)
Table 17. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2020)
Table 18. Ranking of Global Top Regenerative Therapies for Osteoarthritis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Regenerative Therapies for Osteoarthritis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service
Table 22. Date of Enter into Regenerative Therapies for Osteoarthritis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2016-2021)
Table 26. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Regenerative Therapies for Osteoarthritis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2016-2021)
Table 30. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 62. Acelity Company Details
Table 63. Acelity Business Overview
Table 64. Acelity Regenerative Therapies for Osteoarthritis Product
Table 65. Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 66. Acelity Recent Development
Table 67. Mesoblast Company Details
Table 68. Mesoblast Business Overview
Table 69. Mesoblast Regenerative Therapies for Osteoarthritis Product
Table 70. Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 71. Mesoblast Recent Development
Table 72. Nuo Therapeutics Company Details
Table 73. Nuo Therapeutics Business Overview
Table 74. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Product
Table 75. Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 76. Nuo Therapeutics Recent Development
Table 77. Astellas Pharma Company Details
Table 78. Astellas Pharma Business Overview
Table 79. Astellas Pharma Regenerative Therapies for Osteoarthritis Product
Table 80. Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 81. Astellas Pharma Recent Development
Table 82. Organovo Company Details
Table 83. Organovo Business Overview
Table 84. Organovo Regenerative Therapies for Osteoarthritis Product
Table 85. Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 86. Organovo Recent Development
Table 87. Orgenesis Company Details
Table 88. Orgenesis Business Overview
Table 89. Orgenesis Regenerative Therapies for Osteoarthritis Product
Table 90. Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 91. Orgenesis Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Regenerative Therapies for Osteoarthritis Product
Table 95. Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Athersys Company Details
Table 98. Athersys Business Overview
Table 99. Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 100. Athersys Recent Development
Table 101. Takeda Company Details
Table 102. Takeda Business Overview
Table 103. Takeda Regenerative Therapies for Osteoarthritis Product
Table 104. Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 105. Takeda Recent Development
Table 106. Cytori Therapeutics Company Details
Table 107. Cytori Therapeutics Business Overview
Table 108. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Product
Table 109. Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 110. Cytori Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Therapies for Osteoarthritis Market Share by Type: 2020 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Gene Therapy Features
Figure 5. Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Orthopaedic Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Regenerative Therapies for Osteoarthritis Report Years Considered
Figure 11. Global Regenerative Therapies for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Regenerative Therapies for Osteoarthritis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Regenerative Therapies for Osteoarthritis Market Share by Regions: 2020 VS 2027
Figure 14. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2022-2027)
Figure 15. Global Regenerative Therapies for Osteoarthritis Market Share by Players in 2020
Figure 16. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Regenerative Therapies for Osteoarthritis Revenue in 2020
Figure 18. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2016-2021)
Figure 19. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2022-2027)
Figure 20. North America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Regenerative Therapies for Osteoarthritis Market Share by Type (2016-2027)
Figure 22. North America Regenerative Therapies for Osteoarthritis Market Share by Application (2016-2027)
Figure 23. North America Regenerative Therapies for Osteoarthritis Market Share by Country (2016-2027)
Figure 24. United States Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Regenerative Therapies for Osteoarthritis Market Share by Type (2016-2027)
Figure 28. Europe Regenerative Therapies for Osteoarthritis Market Share by Application (2016-2027)
Figure 29. Europe Regenerative Therapies for Osteoarthritis Market Share by Country (2016-2027)
Figure 30. Germany Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Regenerative Therapies for Osteoarthritis Market Share by Region (2016-2027)
Figure 40. China Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Regenerative Therapies for Osteoarthritis Market Share by Type (2016-2027)
Figure 48. Latin America Regenerative Therapies for Osteoarthritis Market Share by Application (2016-2027)
Figure 49. Latin America Regenerative Therapies for Osteoarthritis Market Share by Country (2016-2027)
Figure 50. Mexico Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Regenerative Therapies for Osteoarthritis Market Share by Country (2016-2027)
Figure 56. Turkey Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Acelity Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 60. Mesoblast Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 61. Nuo Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 62. Astellas Pharma Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 63. Organovo Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 64. Orgenesis Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 66. Athersys Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 67. Takeda Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 68. Cytori Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs